Daniel S. Fierer, MD is an Associate Professor in the Division of Infectious Diseases at the Icahn School of Medicine at Mount Sinai. He and his colleagues at Mount Sinai were the first to describe a syndrome of unexpectedly rapid onset and accumulation of hepatic fibrosis after HCV infection in HIV-infected men, a syndrome that appears to resemble the rapid fibrosis progression after HCV infection in patients with other disease-mediated or iatrogenic immunosuppression. In addition to his ongoing investigation into the epidemiology and mechanism of this liver disease, the main focus of his work has been to determine the mechanisms and fluids responsible for HCV infection among men who have sex with men, and to identify and functionally define the enhanced treatment responsiveness period of early HCV to be able to identify those who will be cured with short-course therapy with interferon-free treatments.
At the completion of this educational session, learners will:
- Appreciate the epidemiology of hepatitis C infection among men who have sex with men.
- Understand the behaviors associated with acquisition of hepatitis C during sex among men.
- Be aware of the body fluids in which HCV is shed.
This CME activity was approved for
AMA PRA Category 1 Credit™ on June 20, 2017 and will terminate June 19, 2020.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Fierer (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Gilead common stock. Dr. Fierer will support his presentation and clinical recommendations with the best available evidence from the medical literature, and will submit his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Courses Page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
